Thailand sends trade proposal to the US amid tariff row
Thailand is among the Southeast Asian nations hardest hit by US President Donald Trump's measures, facing a 36 percent tariff on its exports if a reduction can't be negotiated before a global moratorium expires in July.
'We are waiting for the right time to make an appointment to talk, but last week we sent a proposal to America,' Paetongtarn told reporters, adding there had been discussions with representatives from many sectors.
The government has said it would increase imports of US goods, such as corn, soybean meal, crude, ethane, liquefied natural gas, autos and electronics to reduce its bilateral trade surplus with Washington.
Thailand has said it will also promote more Thai investment in the United States and crack down on false claims of origin for products that use Thailand to ship to America.
The United States was Thailand's largest export market last year, taking $55 billion of shipments. Washington has put its deficit with Thailand at $45.6 billion.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Al Arabiya
2 hours ago
- Al Arabiya
Us wants back millions in covid relief from local governments over missing reports
The US Treasury is seeking to recoup COVID-19 pandemic relief funds from hundreds of local governments that received millions of dollars but never complied with requirements to report how they used the money. The federal government distributed 350 billion to state, local, territorial, and tribal governments as part of the American Rescue Plan approved by Congress and President Joe Biden in 2021. More than 30,000 governments from the largest state to the tiniest town were to get a share. Governments had until the end of 2024 to obligate the money for specific projects and were supposed to file either quarterly or annual progress reports depending on their population and how much money they received. Most complied. But as of January, about 1,000 mostly smaller governments had failed to file any reports with the Treasury detailing how they used a total of 139 million, according to an analysis by the US Government Accountability Office. A GAO report released last week said the Treasury sent notices to the local governments seeking to recoup the money. As of June 24, a total of 740 local governments subsequently filed reports and will no longer be subject to repaying their funds, the Treasury said in a letter attached to the GAO report. Thirteen governments returned their funds to the Treasury. But that still left 235 local governments that had never filed a report nor returned their pandemic relief funds. The GAO told The Associated Press it does not have list of the specific governments that haven't complied with the reporting requirements. The Treasury has not responded to an AP request for a list of the 13 governments that returned their funds and those that still haven't reported how they used it. This is not the first time concerns have been raised about governments failing to disclose how they used their pandemic relief funds. The GAO reported in October 2023 that the Treasury had sent noncompliance notices to more than 3,500 local governments that hadn't filed progress reports on their pandemic relief funds. The Treasury at that time declined to provide the noncompliance letters to the AP. So the AP in January 2024 submitted a Freedom of Information Act request seeking copies of the noncompliance notices and related correspondence. The Treasury still has not fulfilled that request. In its most recent report, the GAO said the failure of local governments to file regular progress reports is limiting the Treasury's ability to determine whether they are spending the funds on allowable uses.
Al Arabiya
3 hours ago
- Al Arabiya
Dissent rises at the Federal Reserve among Trump appointees, but interest rate cut is unlikely
WASHINGTON (AP) – Two top Federal Reserve officials could dissent from the central bank's likely decision Wednesday to hold its key interest rate steady–a sign of division at the Fed that reflects the economy's muddy outlook and possibly the jockeying to replace Chair Jerome Powell when his term ends in May 2026. Based on their public comments in the past two months, it's possible that governors Christopher Waller and Michelle Bowman could vote against leaving the short-term rate at about 4.3 percent. If so, it would be the first time two of the seven governors at the Fed have dissented in over three decades. The division could be a preview of what might happen after Powell steps down if President Donald Trump appoints a replacement who pushes for the much lower interest rates the White House desires. Other Fed officials could push back if a future chair sought to cut rates by more than economic conditions would otherwise support. On Wednesday, Trump seized on a report showing the economy expanded at a 3 percent annual rate in the second quarter as evidence that growth is accelerating and called on Powell to cut rates. Yet the Fed typically reduces borrowing costs when the economy is faltering and threatening to send unemployment higher. The economy isn't necessarily doing as well as the 3 percent figure suggests. It follows a negative reading in the first three months of the year when the economy shrank at a 0.5 percent annual rate. Most economists are averaging the two figures to get a growth rate of about 1.25 percent for the first half of the year. If that sluggishness continues, the Fed could cut rates as early as September. For now, any dissent also would likely reflect that there are at least two different ways to see the US economy, which is clearly in flux. The first is the way that most Fed officials have described it: Unemployment is at a low 4.1 percent while the economy is growing, albeit modestly, and inflation did tick up in June largely because of tariffs. So, the thinking goes, why not stand pat on rates and see what happens next? If inflation continues to heat up, a rate cut could make things worse–the Fed typically raises borrowing costs to combat inflation. And as long as the economy is doing well, there is no need to cut to support growth. The other view is more worrisome: There are signs the economy is weakening, such as sluggish hiring, slower consumer spending, and pretty modest overall growth. The economy in the first six months of the year probably expanded at an annual rate of about 1.5 percent. At the same time, tariffs have lifted inflation by less than many economists had feared so far. This is the view of the economy that Waller sketched out in a speech earlier this month. 'Private-sector payroll growth is near stall speed,' Waller said. 'We should not wait until the labor market deteriorates before we cut the policy rate.' When the Fed cuts its rate, it often–but not always–results in lower borrowing costs for mortgages, auto loans, and credit cards. Some economists agree with Waller's concerns about the job market. Excluding government hiring, the economy added just 74,000 jobs in June, with most of those gains occurring in health care. 'We are in a much slower job hiring backdrop than most people appreciate,' said Tom Porcelli, chief US economist at PGIM Fixed Income. Waller was appointed to the Fed's seven-member governing board by Trump during the president's first term. He has often been mentioned as a potential replacement for Powell. Waller has underscored in several speeches that he does not think Trump's tariffs will lead to persistently higher inflation. Bowman, the vice chair for regulation, was also appointed during Trump's first term. She suggested in June that the Fed should soon reduce borrowing costs. Bowman is also a possible Powell replacement, though more of a long shot. Michael Feroli, an economist at JPMorgan Chase, said in a note to clients this week, 'If the pair were to dissent, it would say more about auditioning for the Fed chair appointment than about economic conditions.' The Fed's two-day meeting comes after a week of extraordinary interactions with the Trump White House, which has accused Powell of mismanaging an extensive 2.5 billion renovation of two office buildings. Trump suggested two weeks ago that the rising cost for the project could be a firing offense but has since backed off that characterization. Notably, Trump argues that the Fed should cut because the economy is doing very well, which is a different viewpoint than nearly all economists who say that a healthy growing economy doesn't need rate cuts. 'If your economy is hot, you're supposed to have higher short-term rates,' Porcelli said.
Al Arabiya
5 hours ago
- Al Arabiya
FDA vaccine chief leaving agency after less than three months
The Food and Drug Administration's polarizing vaccine chief is leaving the agency after a brief tenure that drew the ire of biotech companies, patient groups, and conservative allies of President Donald Trump. Dr. Vinay Prasad did not want to be a distraction and was stepping down from his role as the FDA's top vaccine regulator to spend more time with his family, a spokesperson for the Department of Health and Human Services said in a statement late Tuesday. Two people familiar with the situation told The Associated Press that Prasad was ousted following several recent controversies. The people spoke on condition of anonymity to discuss internal personnel matters. Prasad joined the FDA in May after years as an academic researcher at the University of California, San Francisco, where he frequently criticized the FDA's approach to drug approvals and COVID-19 vaccines. His contrarian approach appeared to match FDA Commissioner Marty Makary, who repeatedly praised Prasad's work and intellect. But in recent weeks, Prasad became a target of conservative activists, including Laura Loomer, who flagged Prasad's past statements criticizing Trump and praising liberal independent Senator Bernie Sanders. 'How did this Trump-hating Bernie Bro get into the Trump admin???' Loomer posted on X last week. Prasad also attracted scrutiny for his handling of a recent safety issue surrounding the only approved gene therapy for Duchennes muscular dystrophy. Under his direction, shipments of the therapy were briefly halted after a series of patient deaths, then resumed late Monday following vocal pushback from families of boys with the fatal muscle-wasting disorder. Prasad has long been skeptical of the therapy and other muscular dystrophy drugs sold by the drugmaker Sarepta Therapeutics. As an academic, Prasad gained prominence by attacking the FDA for being too lenient in its standards for approving cancer drugs and other new therapies. That approach is at odds with Trump's Republican supporters, who generally favor speedier approvals and unfettered access to experimental treatments. During Trump's first term, he signed the 'Right to Try' law, a largely symbolic piece of legislation that won popular support from conservatives seeking to give dying patients expanded access to unproven drugs. Prasad's decision to pause Sarepta's therapy was criticized last week by a columnist and the editorial board of The Wall Street Journal. Separately, Prasad's division issued rejection letters this month to three small biotech firms seeking approval for new gene therapies. Prasad's predecessor in the role, Dr. Peter Marks, oversaw a steep rise in approvals for new gene therapies, which aim to treat or prevent disease by replacing or modifying a portion of patients' genetic code. Prasad has been an outspoken critic of Marks' leadership at FDA, which included overseeing the approval of the first COVID vaccines and therapies.
